Synthesis and study of antitumor activity of 4H-pyrano[3,2-c]pyridines based on N-(2-azidoethyl)- and N-propargyl-3,5-bis(arylidene)piperidin-4-ones
- Authors: Bykhovskaya O.V.1, Aladzheva I.M.1, Makarov M.V.1, Rybalkina E.Y.2, Klemenkova Z.S.1, Brel V.K.1
-
Affiliations:
- A. N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences
- Research Institute of Cancerogenesis, N. N. Blokhin Russian Cancer Research Center, Ministry of Health Care of the Russian Federation
- Issue: Vol 66, No 1 (2017)
- Pages: 104-110
- Section: Full Articles
- URL: https://ogarev-online.ru/1066-5285/article/view/239846
- DOI: https://doi.org/10.1007/s11172-017-1707-x
- ID: 239846
Cite item
Abstract
The synthesis of 3,5-bis(arylidene)piperidin-4-ones containing the 2-azidoethyl (azides 1a–d) or propargyl (acetylenes 2a–c) group at the nitrogen atom of the 4-piperidinone ring was described. The in vitro MTT assay for cytotoxicity of these compounds toward the human tumor cell lines PC3, HCT116, and MCF7 and the human embryonic kidney cells HEK293 revealed that N-(2-azidoethyl)-3,5-bis(3-pyridylidene)piperidin-4-one (1c) and N-propargyl-3,5- bis(benzylidene)piperidin-4-one (2a) exhibit high activity (IC50 in the range of 1–5 μmol L–1). The reaction of compounds 1a–d and 2a–c with malononitrile affords the corresponding 4H-pyrano[3,2-c]pyridines 3a–d and 4a–c devoid of cytotoxicity. This is evidence of the importance of preserving the 1,5-diaryl-3-oxo-1,4-pentadiene moiety upon the modification of 3,5-bis(arylidene)piperidin-4-ones in drug design when searching for new antitumor agents based on these compounds.
About the authors
O. V. Bykhovskaya
A. N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences
Email: mmak78@yandex.ru
Russian Federation, 28 ul. Vavilova, Moscow, 119991
I. M. Aladzheva
A. N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences
Email: mmak78@yandex.ru
Russian Federation, 28 ul. Vavilova, Moscow, 119991
M. V. Makarov
A. N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences
Author for correspondence.
Email: mmak78@yandex.ru
Russian Federation, 28 ul. Vavilova, Moscow, 119991
E. Yu. Rybalkina
Research Institute of Cancerogenesis, N. N. Blokhin Russian Cancer Research Center, Ministry of Health Care of the Russian Federation
Email: mmak78@yandex.ru
Russian Federation, 24 Kashirskoe sh., Moscow, 115478
Z. S. Klemenkova
A. N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences
Email: mmak78@yandex.ru
Russian Federation, 28 ul. Vavilova, Moscow, 119991
V. K. Brel
A. N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences
Email: mmak78@yandex.ru
Russian Federation, 28 ul. Vavilova, Moscow, 119991
Supplementary files
